April 7, 2022
Sex Differences in Adverse Events From Cancer Treatments
Women experience more adverse events from chemotherapy than men. However, only a handful of research studies have explored sex differences in immune or targeted therapies. This study, published in the Journal of Clinical Oncology, examines adverse events by sex across these different types of cancer treatment. The researchers looked at treatment-related adverse events by sex in...
Cervical Cancer Trends After the Age of Routine Screening
Cervical cancer screening over age 65 is limited. However, this demographic continues to experience a steady cervical cancer incidence and a worse prognosis. This study, published in Gynecologic Oncology, sought to examine cervical cancer characteristics among women older than 65, including disease, treatment, and survival data, to determine if there is a need to update current cervical cancer...
Cervical Cancer Screening in Hispanics and Sexual Minorities
It is well-known that people who belong to sexual minority groups may face increased risk factors for cancer while simultaneously being less likely to participate in screening. This study, published in Cancer Epidemiology, Biomarkers & Prevention, examined the relationship among sexual minority status, race/ethnicity, and cervical cancer screening rates. The researchers utilized data from the...